UB Paderborn / Katalog / Suche / in CDI

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2022-08, Vol.18 (6), p.482

2022

Link zum Volltext

Verfügbarkeit prüfen

Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark

Journal of the American Heart Association, 2015-01, Vol.4 (1), p.e001399-e001399

2015

Link zum Volltext

Verfügbarkeit prüfen

Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial

Heart (British Cardiac Society), 2018-10, Vol.104 (19), p.1593

2018

Link zum Volltext

Verfügbarkeit prüfen

Stent Thrombosis, Myocardial Infarction, and Death After Drug-Eluting and Bare-Metal Stent Coronary Interventions

Journal of the American College of Cardiology, 2007-07, Vol.50 (5), p.463-470

2007

Link zum Volltext

Verfügbarkeit prüfen

A Common Variant in SCN5A and the Risk of Ventricular Fibrillation Caused by First ST-Segment Elevation Myocardial Infarction

PloS one, 2017-01, Vol.12 (1), p.e0170193-e0170193

2017

Link zum Volltext

Verfügbarkeit prüfen

Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study

The American heart journal, 2018-10, Vol.204, p.128-138

2018

Link zum Volltext

Verfügbarkeit prüfen

A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the diabedES IV randomized angiography trial)

Catheterization and cardiovascular interventions, 2015-12, Vol.86 (7), p.1161-1167

2015

Link zum Volltext

Verfügbarkeit prüfen

Microcirculatory Function in Nonhypertrophic and Hypertrophic Myocardium in Patients With Aortic Valve Stenosis

Journal of the American Heart Association, 2022-05, Vol.11 (9), p.e025381-e025381

2022

Link zum Volltext

Verfügbarkeit prüfen

MR‐proADM as a Prognostic Marker in Patients With ST‐Segment–Elevation Myocardial Infarction—DANAMI‐3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy

Journal of the American Heart Association, 2018-06, Vol.7 (11), p.n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: From Western Denmark heart registry

Catheterization and cardiovascular interventions, 2014-06, Vol.83 (7), p.1035-1042

2014

Link zum Volltext

Verfügbarkeit prüfen

Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy)

The American journal of cardiology, 2018-04, Vol.121 (7), p.781-788

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus - and Sirolimus -Eluting Stents (from the SORT OUT IV Trial)

The American journal of cardiology, 2012-12, Vol.110 (11), p.1585-1591

2012

Link zum Volltext

Verfügbarkeit prüfen

Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction

The American heart journal, 2015-07, Vol.170 (1), p.70-78

2015

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Safety and Efficacy of Everolimus- Versus Sirolimus-Eluting Stents: 5-Year Results From SORT OUT IV

Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial

Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial

Randomized Comparison of Everolimus-Eluting and Sirolimus-Eluting Stents in Patients Treated With Percutaneous Coronary Intervention: The Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV)

Rationale and Design of a Randomized Clinical Comparison of Everolimus-Eluting (Xience V/Promus) and Sirolimus-Eluting (Cypher Select+) Coronary Stents in Unselected Patients with Coronary Heart Disease

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

Treatment of cardiogenic shock with percutanous mechanical circulatory support

International randomized trial on the effect of revascularization or optimal medical therapy of chronic total coronary occlusions with myocardial ischemia - ISCHEMIA-CTO trial – rationale and design

Long-Term Changes in Invasive Physiological Pressure Indices of Stenosis Severity Following Transcatheter Aortic Valve Implantation

Outcomes after primary percutaneous coronary intervention in octogenarians and nonagenarians with ST-segment elevation myocardial infarction: From the Western Denmark heart registry

Clinical outcomes of no stenting in patients with ST-segment elevation myocardial infarction undergoing deferred primary percutaneous coronary intervention

Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark

Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial

Stent Thrombosis, Myocardial Infarction, and Death After Drug-Eluting and Bare-Metal Stent Coronary Interventions

A Common Variant in SCN5A and the Risk of Ventricular Fibrillation Caused by First ST-Segment Elevation Myocardial Infarction

Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study

A 10-month angiographic and 4-year clinical outcome of everolimus-eluting versus sirolimus-eluting coronary stents in patients with diabetes mellitus (the diabedES IV randomized angiography trial)

Microcirculatory Function in Nonhypertrophic and Hypertrophic Myocardium in Patients With Aortic Valve Stenosis

MR‐proADM as a Prognostic Marker in Patients With ST‐Segment–Elevation Myocardial Infarction—DANAMI‐3 (a Danish Study of Optimal Acute Treatment of Patients With STEMI) Substudy

Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: From Western Denmark heart registry

Impact of Health Care System Delay in Patients With ST-Elevation Myocardial Infarction on Return to Labor Market and Work Retirement

Relation of Bleeding Events to Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated by Percutaneous Coronary Intervention (a DANAMI-3 Substudy)

Comparison of Outcomes in Patients With Versus Without Diabetes Mellitus After Revascularization With Everolimus - and Sirolimus -Eluting Stents (from the SORT OUT IV Trial)

Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction

Suchergebnisse filtern